Reply-histologic Chorioamnionitis and Neonatal Outcome in Preterm Infants.

Zhi-Wei Liu,Yi Yang

DOI: https://doi.org/10.1016/j.pedneo.2013.08.006

2013-01-01

Abstract:Some readers were confused by about the data in Table 2 in our article, and they wanted us to explain the discrepancy that the incidence of respiratory distress syndrome (RDS) and the use of mechanical ventilation was significantly lower in infants in the MIR+FIR− group or MIR+FIR+ group than in infants in the MIR-FIR- group, but the incidence of pulmonary surfactant (PS) administration was similar among the three groups. In our preterm newborns, the PS administration was used not only for RDS treatment, but also for prophylactic therapy. Therefore, some cases in each group that received PS administration were not RDS patients. We think that this is the main reason for the discrepancy. It is widely accepted that bronchopulmonary dysplasia (BPD) is a consequence of lung inflammation that is caused by intrauterine infection and/or postnatal inflammation. A meta-analysis of clinical studies showed that chorioamnionitis was significantly associated with BPD.1Hartling L. Liang Y. Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis.Arch Dis Child Fetal Neonatal Ed. 2012; 97: F8-F17Crossref PubMed Scopus (177) Google Scholar However, we were unable to confirm the association between placental inflammation and bronchopulmonary dysplasia (BPD) from our clinical data analysis. Low gestational age is a very important risk factor for BPD, and the incidence of BPD significantly decreases with the increase in gestational age. We therefore suggested that one of possible explanation is that the patient population of our study was relatively older, although other variable factors cannot be excluded. The relationship between intrauterine inflammation and BPD is very complicated. Postnatal inflammation also plays an important role. A clinical study has shown that prolonged mechanical ventilation or postnatal infection interacts with antenatal infection to further increase the risk of chronic lung disease in preterm neonates.2Van Marter L.J. Dammann O. Allred E.N. Leviton A. Pagano M. Moore M. et al.Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants.J Pediatr. 2002; 140: 171-176Abstract Full Text Full Text PDF PubMed Scopus (300) Google Scholar PS components can decrease harmful lung inflammatory responses, and animal-derived PS extract is associated with a decreased risk of BPD.3Seger N. Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome.Cochrane Database Syst Rev. 2009; 2: CD007836PubMed Google Scholar Therefore, PS is widely used as a prophylactic therapy for our preterm newborns, which may also mitigate the effect of placental inflammation on the development of BPD. More studies are needed to clarify the relationship between placental inflammations, postnatal inflammation, medical intervention, and BPD. The authors have no conflicts of interest relevant to this article. Histological Chorioamnionitis and Neonatal Outcome in Preterm InfantsPediatrics & NeonatologyVol. 55Issue 2PreviewThe article by Liu et al researched the association between placental inflammation and neonatal outcomes.1 The placental inflammation was classified as maternal inflammatory response (MIR) and fetal inflammatory response (FIR) in accordance with the definition by the Amniotic Fluid Infection Nosology Committee. Based on the placental pathology, the study population was divided into three groups: (1) MIR−FIR− group; (2) MIR+FIR+ group; and (3) MIR+FIR− group. Full-Text PDF Open Archive